AcouSort AB (ACOU.ST) Stock Analysis & Winston Score

AcouSort is a small Swedish biotech company that uses sound waves to sort and separate tiny biological particles, like cells and bacteria, inside lab equipment. This technology is called acoustofluidics, and it is used in medical research, diagnostics, and life science tools. The company sells its technology to research labs, instrument makers, and healthcare companies that need precise ways to handle biological samples. AcouSort makes money by selling hardware modules, licensing its technology to other companies, and through research collaboration agreements. It operates primarily in Sweden and sells into European and global life science markets. The company is very small, with a market cap around $100 million, and its negative gross and operating margins show it is still in an early, pre-commercial stage burning through cash. The key risk is that it must successfully move from research partnerships to scalable product revenue before its funding runs out, which is a common and serious challenge for early-stage biotech companies.